Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2115INDUSTRY 1109NIH 207NETWORK 93OTHER_GOV 39FED 3INDIV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 2Lymphoid 2Sarcoma 1

Conditions

Prostatic Neoplasms 53Colorectal Neoplasms 42Neoplasms 37Lung Neoplasms 22Breast Neoplasms 15Colonic Neoplasms 14Colonic Polyps 13Rare Diseases 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 9Ovarian Neoplasms 7Adenoma 7Pulmonary Disease, Chronic Obstructive 6Neoplasm Metastasis 6Heart Failure 6Rectal Neoplasms 5Motor Activity 5Liver Neoplasms 5Head and Neck Neoplasms 5Fibrosis 5Carcinoma, Squamous Cell 5Barrett Esophagus 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Neoplasms by Site 4Mental Disorders 4Lymphoma 4Lung Diseases 4Leukemia 4Esophageal Neoplasms 4

Interventions

selinexor 1Topotecan 1Mitoxantrone 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
FED × Multiple Myeloma × Clear all
NCT04364256 2026-01-02

Muscle Stimulation for Physical Function During Stem Cell Transplant

VA Office of Research and Development

Phase NA Completed
46 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Muscular Atrophy, Hematologic Neoplasms

NCT06452446 2025-02-10

Selinexor

Durham VA Medical Center

Active not recruiting
20 enrolled
Plasma cellSarcoma

Multiple Myeloma, Dendritic Cell Sarcoma, Interdigitating

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

VA Office of Research and Development

Phase 2 Completed
10 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡